Berkshire Hathaway Inc. (BRK-A)

Key Updates

Berkshire Hathaway shares rebounded 2.04% to $730,292 since the May 28 report, recovering from the prior period's -2.01% decline but remaining down -3.25% YTD. The recovery follows confirmation of Greg Abel's strategic direction through two megadeals: a $6.8 billion acquisition of Taylor Morrison and a $10 billion expansion of the Alphabet position. These transactions, alongside Q1 portfolio restructuring including a $2.6 billion Delta Air Lines investment, demonstrate Abel's willingness to deploy capital aggressively while maintaining Buffett's value-oriented principles. However, structural concerns persist as Berkshire's relative performance versus the S&P 500 has deteriorated to 2007 levels, with the stock down 4% YTD compared to the index's 9% gain, highlighting challenges in an AI-driven market where Berkshire maintains limited exposure despite holding $400 billion in cash.

Current Trend

Berkshire trades at $730,292, approximately 6% below all-time highs and down -3.25% YTD, underperforming the S&P 500's 9% gain by 1,300 basis points. Short-term momentum shows improvement with gains of 1.65% (1d), 2.73% (5d), and 3.45% (1m), reversing the six-month decline of -3.37%. The stock has established a near-term support level around $715,000 tested in late May, while resistance persists at prior highs near $775,000. The recent recovery reflects market reception to Abel's strategic initiatives, though the stock remains range-bound as investors assess the leadership transition and capital deployment strategy. Trading volumes and price action suggest cautious optimism tempered by concerns over relative market underperformance and the $400 billion cash position's drag on returns in rising equity markets.

Investment Thesis

The investment thesis centers on Berkshire's diversified conglomerate structure generating sustainable cash flows through insurance operations (projected 46% of pretax earnings), wholly-owned businesses, and an equity portfolio now valued at moderate discount to Morningstar's $765,000 fair value estimate. Under Abel's leadership, the company is demonstrating capacity for large-scale capital deployment through the Taylor Morrison acquisition and Alphabet position expansion, addressing prior concerns about cash utilization. The thesis assumes Berkshire maintains its competitive advantages in insurance underwriting, particularly through Geico and reinsurance operations representing 51% of firm valuation, while gradually deploying excess cash estimated at $331.8 billion. Key to the thesis is Abel's ability to generate returns comparable to Buffett's historical performance while navigating a technology-dominated market where Berkshire has structural underweight positions in AI beneficiaries. The moderate undervaluation at 1.35-1.45x estimated 2026-2027 book value provides downside protection, though upside depends on successful integration of new acquisitions and improved relative market performance.

Thesis Status

The thesis is partially validated but facing execution challenges. Abel's megadeals confirm capital deployment capability, directly addressing the primary concern from previous reports regarding the $400 billion cash drag. The $6.8 billion Taylor Morrison acquisition provides exposure to housing markets, while the $10 billion Alphabet investment increases technology exposure to $27 billion total position, now the seventh-largest holding. However, the thesis is pressured by persistent relative underperformance—Berkshire's technical analysis shows performance has reverted to 2007 levels versus the S&P 500, indicating two decades of minimal relative progress. The Q1 portfolio restructuring, including exits from Amazon, Visa, Mastercard, and UnitedHealth, reflects strategic repositioning but also removes growth-oriented positions. Insurance operations remain on track to deliver projected earnings contributions, supporting the fundamental thesis. The critical test ahead is whether Abel's transaction strategy can reverse the structural underperformance trend while maintaining Berkshire's risk-adjusted return profile. Morningstar's Low uncertainty rating and 4-star valuation at current levels suggest the thesis holds at a 5% discount to fair value, though the margin of safety has compressed from deeper discounts seen in prior periods.

Key Drivers

Capital deployment acceleration represents the primary near-term catalyst, with Abel's $16.8 billion in megadeals signaling willingness to utilize the cash position aggressively. The Taylor Morrison acquisition provides immediate earnings accretion in homebuilding, while the Alphabet expansion increases technology exposure at a critical juncture for AI development. Portfolio restructuring continues with Q1 purchases of $16 billion against $24 billion in sales, including the $2.6 billion Delta Air Lines position marking return to airlines after the 2020 pandemic exit. Insurance operations remain the fundamental driver, projected to generate 46% of pretax earnings over five years according to Morningstar analysis. The leadership transition under Abel is progressing with his first annual meeting successfully completed, though relative performance erosion to 2007 levels versus the S&P 500 presents a structural headwind requiring strategic response through either increased buybacks from the modest resumption or transformative acquisitions beyond current deals.

Technical Analysis

Berkshire trades at $730,292, establishing a recovery pattern from the $715,000 support level tested during the late May pullback. The stock remains 6% below all-time highs near $775,000, which now serves as near-term resistance. Short-term momentum indicators are positive with consecutive gains over 1-day (1.65%), 5-day (2.73%), and 1-month (3.45%) periods, suggesting a potential trend reversal from the six-month decline of -3.37%. The YTD performance of -3.25% indicates the stock is trading within a consolidation range between $715,000-$775,000, with the current price near the middle of this band. Volume patterns around the megadeal announcements suggest institutional interest, though the stock has failed to break out decisively above resistance. The relative strength versus the S&P 500 remains weak, with Berkshire underperforming by 1,300 basis points YTD, creating a technical divergence that requires fundamental catalysts to resolve. Key technical levels to monitor include support at $715,000 and resistance at $750,000 (near-term) and $775,000 (intermediate-term), with a break above the latter needed to confirm a bullish trend reversal.

Bull Case

• Abel's $16.8 billion in megadeals demonstrates aggressive capital deployment capability, directly addressing the $400 billion cash drag concern and signaling strategic shift toward utilizing excess liquidity through the $6.8 billion Taylor Morrison acquisition and $10 billion Alphabet expansion, providing immediate earnings accretion and increased technology exposure in AI-driven markets.
• Morningstar's valuation analysis establishes fair value at $765,000 per share, representing 5% upside from current levels, with the stock trading at attractive 1.35-1.45x estimated 2026-2027 book value multiples and Low uncertainty rating supporting a 4-star recommendation, indicating favorable risk-reward profile for long-term investors.
• Insurance operations provide durable competitive advantage with projected 46% contribution to pretax earnings over five years and 51% of firm valuation, with $373.1 billion in cash and $331.8 billion in excess cash available for additional acquisitions, investments, and share repurchases beyond current deployments.
• Portfolio repositioning increases growth potential through tripled Alphabet stake to 58 million shares worth $17 billion and strategic $2.6 billion Delta Air Lines investment, positioning the company for cyclical recovery in airlines while maintaining technology exposure in AI leaders.
• Short-term technical momentum shows consistent gains across 1-day (1.65%), 5-day (2.73%), and 1-month (3.45%) periods, with established support at $715,000 providing downside protection while the stock recovers from YTD lows, suggesting potential trend reversal as market reception to Abel's strategic initiatives improves investor sentiment.

Bear Case

• Structural relative performance deterioration shows Berkshire has returned to 2007 performance levels versus the S&P 500, indicating minimal relative progress over two decades, with YTD underperformance of 1,300 basis points (down 4% versus index gain of 9%) highlighting fundamental challenges in AI-dominated markets where Berkshire maintains limited exposure.
• Massive $400 billion cash position continues to act as performance drag during rising equity markets, with only modest share buyback resumption under Abel following nearly two-year hiatus, suggesting capital deployment remains insufficient relative to cash generation despite recent megadeals totaling $16.8 billion.
• Portfolio restructuring eliminates growth-oriented positions with complete exits from Amazon, UnitedHealth, Visa, and Mastercard in Q1, removing exposure to secular growth trends in e-commerce, healthcare technology, and digital payments while Q1 net selling of $8 billion indicates continued defensive positioning.
• Leadership transition uncertainty persists as Abel executes his first full year as CEO, with departure of investment manager Todd Combs to JPMorgan reducing bench strength and raising questions about Abel's ability to replicate Buffett's historical outperformance in fundamentally different market conditions dominated by technology and AI.
• Technical resistance at $775,000 all-time highs remains unbreached with stock trading 6% below peak levels, while Buffett's 2023 acknowledgment that Berkshire's size limits outperformance potential suggests structural headwinds to future alpha generation as the company's $730 billion market capitalization constrains investment opportunities and return potential.